KERRERA TINDAL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner COLUMBIA, SC NPI 1538779178
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SC Ardelyx, Inc. All categories
General Payments — all program years on this page
$378.66
- Category: General Payments
- Program years: PY2023–2024
- Record count: 17
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $186.89 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $186.89 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Ardelyx, Inc. | $50.85 | 2 |
| Acerta Pharma LLC | $45.96 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $43.89 | 2 |
| CALLIDITAS THERAPEUTICS US INC. | $23.35 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.84 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1086284866 | Bayer Healthcare Pharmaceuticals Inc. | $16.52 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1086309487 | Bayer Healthcare Pharmaceuticals Inc. | $27.37 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105365787 | AstraZeneca Pharmaceuticals LP | $27.75 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105642554 | AstraZeneca Pharmaceuticals LP | $18.21 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119201238 | Otsuka America Pharmaceutical, Inc. | $22.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1141518271 | CALLIDITAS THERAPEUTICS US INC. | $23.35 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146748089 | Ardelyx, Inc. | $28.85 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1146748091 | Ardelyx, Inc. | $22.00 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.